This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Charlotte, NC-based Albemarle Corporation is a premier specialty chemicals company with leading positions in attractive end markets globally. It is a leading producer of highly-engineered specialty chemicals geared to meet customer requirements across a bevy of end markets including petroleum refining, consumer electronics, energy storage, construction and automotive.
Albemarle (ALB) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Albemarle (ALB) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Albemarle's (ALB) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Albemarle (ALB) lags Q3 estimates despite higher volumes in the lithium business.
Albemarle (ALB) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Albemarle (ALB) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Should You Buy Albemarle (ALB) Ahead of Earnings?
by Zacks Equity Research
Albemarle (ALB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Albemarle (ALB) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher lithium volumes and its cost-reduction actions in Q3 amid demand headwinds in specialties.
These 2 Basic Materials Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Eastman Chemical (EMN) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of 1.38% and 0.28%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Albemarle (ALB) Stock Moves -0.08%: What You Should Know
by Zacks Equity Research
In the latest trading session, Albemarle (ALB) closed at $135.21, marking a -0.08% move from the previous day.
Analysts Estimate Avient (AVNT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Avient (AVNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Albemarle (ALB) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Albemarle (ALB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Albemarle Corporation (ALB) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Albemarle (ALB). This makes it worthwhile to examine what the stock has in store.
Albemarle (ALB) Completes MARBL Joint Venture Restructuring
by Zacks Equity Research
Albemarle (ALB) completes MARBL JV restructuring and takes full ownership of Kemerton facility.
Zacks Market Edge Highlights: ALB, ZM, FTCH, JD and PYPL
by Zacks Equity Research
ALB, ZM, FTCH, JD and PYPL have been highlighted in this Market Edge article.
Stocks on Sale: How Low Will They Go?
by Tracey Ryniec
While many stocks rallied to start 2023, others have not and are hitting new 52-week lows. Are they deals?
Albemarle (ALB) Withdraws Offer to Acquire Liontown Resources
by Zacks Equity Research
Albemarle (ALB) withdraws its offer to acquire Liontown Resources due to increasing complexities associated with the transaction.
Albemarle (ALB) Gains on Strong Lithium Demand, Expansion Moves
by Zacks Equity Research
While Albemarle (ALB) faces headwinds from softness in specialties, it gains on higher lithium demand and actions to boost its global lithium capacity.
Investors Heavily Search Albemarle Corporation (ALB): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Albemarle (ALB). This makes it worthwhile to examine what the stock has in store.
Why Albemarle (ALB) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Will Albemarle (ALB) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Albemarle (ALB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Investors Need to Take Advantage of These 2 Basic Materials Stocks Now
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Albemarle (ALB) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Albemarle (ALB) closed at $170.04, marking a -1.37% move from the previous day.
Albemarle (ALB)-Caterpillar Join Forces for Sustainable Mining
by Zacks Equity Research
Albemarle (ALB) and Caterpillar team up to develop a more sustainable battery supply chain, including zero-emissions lithium mining and advancements in battery cell technology.
Want Better Returns? Don?t Ignore These 2 Basic Materials Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Albemarle (ALB) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Albemarle (ALB) closed at $168.21, marking a -0.43% move from the previous day.
Here is What to Know Beyond Why Albemarle Corporation (ALB) is a Trending Stock
by Zacks Equity Research
Albemarle (ALB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.